80 related articles for article (PubMed ID: 16412570)
1. Intracellular localization and concentration as well as photodynamic effects of benzoporphyrin derivative monoacid ring A in four types of rodent tumor cells.
Osaki T; Takagi S; Hoshino Y; Okumura M; Fujinaga T
Cancer Lett; 2006 Nov; 243(2):281-92. PubMed ID: 16412570
[TBL] [Abstract][Full Text] [Related]
2. Calculation of singlet oxygen dose using explicit and implicit dose metrics during benzoporphyrin derivative monoacid ring A (BPD-MA)-PDT in vitro and correlation with MLL cell survival.
Weston MA; Patterson MS
Photochem Photobiol; 2011; 87(5):1129-37. PubMed ID: 21575000
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrion-targeted photosensitizer enhances the photodynamic effect-induced mitochondrial dysfunction and apoptosis.
Peng TI; Chang CJ; Guo MJ; Wang YH; Yu JS; Wu HY; Jou MJ
Ann N Y Acad Sci; 2005 May; 1042():419-28. PubMed ID: 15965088
[TBL] [Abstract][Full Text] [Related]
4. Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin).
Akens MK; Hardisty MR; Wilson BC; Schwock J; Whyne CM; Burch S; Yee AJ
Breast Cancer Res Treat; 2010 Jan; 119(2):325-33. PubMed ID: 19263216
[TBL] [Abstract][Full Text] [Related]
5. Cellular distribution and phototoxicity of benzoporphyrin derivative and Photofrin.
Rousset N; Vonarx V; Eléouet S; Carré J; Bourré L; Lajat Y; Patrice T
Res Exp Med (Berl); 2000 Jun; 199(6):341-57. PubMed ID: 10945652
[TBL] [Abstract][Full Text] [Related]
6. Efficient induction of apoptosis in HeLa cells by a novel cationic porphycene photosensitizer.
Ruiz-González R; Acedo P; Sánchez-García D; Nonell S; Cañete M; Stockert JC; Villanueva A
Eur J Med Chem; 2013 May; 63():401-14. PubMed ID: 23517729
[TBL] [Abstract][Full Text] [Related]
7. Intracellular target for photosensitization in cancer antiangiogenic photodynamic therapy mediated by polycation liposome.
Takeuchi Y; Ichikawa K; Yonezawa S; Kurohane K; Koishi T; Nango M; Namba Y; Oku N
J Control Release; 2004 Jun; 97(2):231-40. PubMed ID: 15196750
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of contact hypersensitivity with different analogs of benzoporphyrin derivative.
Simkin GO; King DE; Levy JG; Chan AH; Hunt DW
Immunopharmacology; 1997 Oct; 37(2-3):221-30. PubMed ID: 9403341
[TBL] [Abstract][Full Text] [Related]
9. Photosensitising potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model.
Richter AM; Waterfield E; Jain AK; Allison B; Sternberg ED; Dolphin D; Levy JG
Br J Cancer; 1991 Jan; 63(1):87-93. PubMed ID: 1989669
[TBL] [Abstract][Full Text] [Related]
10. Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer.
Takeuchi Y; Kurohane K; Ichikawa K; Yonezawa S; Nango M; Oku N
Cancer; 2003 Apr; 97(8):2027-34. PubMed ID: 12673734
[TBL] [Abstract][Full Text] [Related]
11. Explicit macroscopic singlet oxygen modeling for benzoporphyrin derivative monoacid ring A (BPD)-mediated photodynamic therapy.
Kim MM; Penjweini R; Liang X; Zhu TC
J Photochem Photobiol B; 2016 Nov; 164():314-322. PubMed ID: 27721165
[TBL] [Abstract][Full Text] [Related]
12. Verteporfin mediated sequence dependent combination therapy against ovarian cancer cell line.
Erdem SS; Obeidin VA; Yigitbasi T; Tumer SS; Yigit P
J Photochem Photobiol B; 2018 Jun; 183():266-274. PubMed ID: 29747146
[TBL] [Abstract][Full Text] [Related]
13. Polycation liposome enhances the endocytic uptake of photosensitizer into cells in the presence of serum.
Takeuchi Y; Kurohane K; Ichikawa K; Yonezawa S; Ori H; Koishi T; Nango M; Oku N
Bioconjug Chem; 2003; 14(4):790-6. PubMed ID: 12862432
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growth.
Ichikawa K; Takeuchi Y; Yonezawa S; Hikita T; Kurohane K; Namba Y; Oku N
Cancer Lett; 2004 Mar; 205(1):39-48. PubMed ID: 15036659
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effects and blood flow dynamics after photodynamic therapy using benzoporphyrin derivative monoacid ring A in KLN205 and LM8 mouse tumor models.
Osaki T; Takagi S; Hoshino Y; Okumura M; Fujinaga T
Cancer Lett; 2007 Apr; 248(1):47-57. PubMed ID: 16837129
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity.
Pogue BW; O'Hara JA; Demidenko E; Wilmot CM; Goodwin IA; Chen B; Swartz HM; Hasan T
Cancer Res; 2003 Mar; 63(5):1025-33. PubMed ID: 12615718
[TBL] [Abstract][Full Text] [Related]
17. Skin necrosis due to photodynamic action of benzoporphyrin depends on circulating rather than tissue drug levels: implications for control of photodynamic therapy.
Lin GC; Tsoukas ML; Lee MS; González S; Vibhagool C; Anderson RR; Kollias N
Photochem Photobiol; 1998 Oct; 68(4):575-83. PubMed ID: 9796441
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic photodynamic therapy with targeted liposomes.
Oku N; Ishii T
Methods Enzymol; 2009; 465():313-30. PubMed ID: 19913174
[TBL] [Abstract][Full Text] [Related]
19. Photosensitizing efficiency of two regioisomers of the benzoporphyrin derivative monoacid ring A (BPD-MA).
Richter AM; Jain AK; Canaan AJ; Waterfield E; Sternberg ED; Levy JG
Biochem Pharmacol; 1992 Jun; 43(11):2349-58. PubMed ID: 1610400
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics of anti-angiogenic photodynamic therapy with benzoporphyrin derivative monoacid ring-A in dogs having naturally occurring neoplasms.
Osaki T; Hoshino S; Hoshino Y; Takagi S; Okumura M; Kadosawa T; Fujinaga T
J Vet Med A Physiol Pathol Clin Med; 2006 Mar; 53(2):108-12. PubMed ID: 16466464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
